210 related articles for article (PubMed ID: 25621995)
1. Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21).
Panagopoulos I; Gorunova L; Bjerkehagen B; Heim S
PLoS One; 2015; 10(1):e0117010. PubMed ID: 25621995
[TBL] [Abstract][Full Text] [Related]
2. Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12).
Panagopoulos I; Gorunova L; Bjerkehagen B; Heim S
PLoS One; 2015; 10(4):e0124288. PubMed ID: 25875009
[TBL] [Abstract][Full Text] [Related]
3. Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman.
Ainsworth AJ; Dashti NK; Mounajjed T; Fritchie KJ; Davila J; Mopuri R; Jackson RA; Halling KC; Bakkum-Gamez JN; Schoolmeester JK
Diagn Pathol; 2019 Apr; 14(1):32. PubMed ID: 31027501
[TBL] [Abstract][Full Text] [Related]
4. Genetic heterogeneity in leiomyomas of deep soft tissue.
Panagopoulos I; Gorunova L; Brunetti M; Agostini A; Andersen HK; Lobmaier I; Bjerkehagen B; Heim S
Oncotarget; 2017 Jul; 8(30):48769-48781. PubMed ID: 28591699
[TBL] [Abstract][Full Text] [Related]
5. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract][Full Text] [Related]
6. The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features.
Trecourt A; Azmani R; Hostein I; Blanchard L; Le Loarer F; Bourdon A; Alame M; Nadaud B; Mayer L; Rebier F; Larmonier C; Moura MS; Soubeyran I; Hartog C; Ray-Coquard I; Treilleux I; Devouassoux-Shisheboran M; Croce S
Mod Pathol; 2023 Oct; 36(10):100243. PubMed ID: 37307879
[TBL] [Abstract][Full Text] [Related]
7. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
8. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
[TBL] [Abstract][Full Text] [Related]
10. Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma.
Schoenmakers EF; Bunt J; Hermers L; Schepens M; Merkx G; Janssen B; Kersten M; Huys E; Pauwels P; Debiec-Rychter M; van Kessel AG
Genes Chromosomes Cancer; 2013 Jan; 52(1):11-23. PubMed ID: 22965931
[TBL] [Abstract][Full Text] [Related]
11. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
12. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
Di Tommaso S; Tinelli A; Malvasi A; Massari S
Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
[TBL] [Abstract][Full Text] [Related]
13. Expression of erythropoietin messenger ribonucleic acid in wild-type MED12 uterine leiomyomas under estrogenic influence: new insights into related growth disparities.
Asano R; Asai-Sato M; Matsukuma S; Mizushima T; Taguri M; Yoshihara M; Inada M; Fukui A; Suzuki Y; Miyagi Y; Miyagi E
Fertil Steril; 2019 Jan; 111(1):178-185. PubMed ID: 30554729
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors.
Je EM; Kim MR; Min KO; Yoo NJ; Lee SH
Int J Cancer; 2012 Sep; 131(6):E1044-7. PubMed ID: 22532225
[TBL] [Abstract][Full Text] [Related]
15. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).
Panagopoulos I; Fioretos T; Isaksson M; Samuelsson U; Billström R; Strömbeck B; Mitelman F; Johansson B
Hum Mol Genet; 2001 Feb; 10(4):395-404. PubMed ID: 11157802
[TBL] [Abstract][Full Text] [Related]
16. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
17. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
[TBL] [Abstract][Full Text] [Related]
18. Fusion of HMGA2 to COG5 in uterine leiomyoma.
Velagaleti GV; Tonk VS; Hakim NM; Wang X; Zhang H; Erickson-Johnson MR; Medeiros F; Oliveira AM
Cancer Genet Cytogenet; 2010 Oct; 202(1):11-6. PubMed ID: 20804914
[TBL] [Abstract][Full Text] [Related]
19. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
Croce S; Chibon F
Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
[TBL] [Abstract][Full Text] [Related]
20. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
